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Abstract
Background: Community samples suggest that approximately 1 in 20 children and adults exhibit clinically significant anger,
hostility, and aggression. Individuals with dysregulated emotional control have a greater lifetime burden of psychiatric
morbidity, severe impairment in role functioning, and premature mortality due to cardiovascular disease.
Methods: With publically available data secured from dbGaP, we conducted a genome-wide association study of proneness
to anger using the Spielberger State-Trait Anger Scale in the Atherosclerosis Risk in Communities (ARIC) study (n = 8,747).
Results: Subjects were, on average, 54 (range 45–64) years old at baseline enrollment, 47% (n = 4,117) were male, and all
were of European descent by self-report. The mean Angry Temperament and Angry Reaction scores were 5.861.8 and
7.662.2. We observed a nominally significant finding (p = 2.9E-08, l= 1.027 - corrected pgc = 2.2E-07, l= 1.0015) on
chromosome 6q21 in the gene coding for the non-receptor protein-tyrosine kinase, Fyn.
Conclusions: Fyn interacts with NDMA receptors and inositol-1,4,5-trisphosphate (IP3)-gated channels to regulate calcium
influx and intracellular release in the post-synaptic density. These results suggest that signaling pathways regulating
intracellular calcium homeostasis, which are relevant to memory, learning, and neuronal survival, may in part underlie the
expression of Angry Temperament.
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Introduction
Anger has been characterized as a complex construct encom-
passing irritability, hostility, and aggressive behavior. Its compo-
nents -- impulsive, unprovoked, and developmentally inappropri-
ate outbursts of anger – may be associated with dysregulated
emotional control or impaired neural circuits mediating emotion,
cognition, and inhibition [1,2]. Approximately 5% of children and
adults in community samples exhibit extreme levels of anger,
hostility, and aggression considered to be clinically significant [3–
5].
Further, these traits are strongly associated with a range of
psychiatric symptomatology. Behavioral dysregulation and aggres-
sion also predict psychiatric hospitalization and suicidality in
childhood and a wide range of psychiatric morbidity in adulthood
[6–11]. Moreover, dysregulated emotional control and intermit-
tent explosive disorder in adults is associated with a greater lifetime
burden of psychiatric morbidity and severe impairment in role
functioning [2,5]. Proneness to anger in the general community is
also associated with premature all-cause mortality [12], primarily
due to cardiovascular disease [13–18]. Consequently, effective
primary or secondary interventions that reduce anger, hostility,
and aggression might have a substantial public health impact on
quality of life and, ultimately, longevity.
Symptoms of deficient emotional self-regulation in adults are
familial [19] and, as recently shown in the Vietnam Era Twin
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Registry, are influenced by moderate genetic effects, particularly
on the tendency to switch from euthymia to depression or anger
[20]. A commonly used continuously-distributed measure of this
trait in children, the Child Behavior Checklist Dysregulation
Profile, has been found to be highly heritable with additive genetic
effects consistently explaining up to 67% of its variance
[3,4,21,22]. A small GWAS of this trait in children with
attention-deficit hyperactivity disorder suggested possible associa-
tions with several genes implicated in neurodevelopment, synaptic
plasticity, as well as hippocampal dependent memory and learning
[23]. Taken together, these studies suggest the role of heritable
factors in determining individual differences in the self-regulation
of emotional and cognitive neural circuits, ones that may underlie
proneness to anger, hostility, and aggression. The primary goal of
this study was to identify genetic susceptibility loci for proneness to
anger through a secondary analysis of publically-available data.
Materials and Methods
Phenotypes and genotypes were downloaded from the National
Center for Biotechnology Information (NCBI) database of
genotypes and phenotypes (dbGaP) [24] for the NHLBI funded
Atherosclerosis Risk in Communities (ARIC) Study (Accessions:
phs000280.v1.p1 and phs000090.v1.p1). In accord with the
restrictions on the use of the data defined by participant informed
consent agreements, this ARIC dataset may be used for general
research use following the approval of the ARIC Data Access
Committee and IRB approval at the approved investigators
institution. The acquisition and use of these data was approved
and overseen by the Human Subjects Institutional Review Board
at the University of Massachusetts Medical School.
Atherosclerosis Risk in Communities (ARIC) Cohort
Details regarding the design and objectives of the Atheroscle-
rosis Risk in Communities Study have been previously published
and are available online (http://www.cscc.unc.edu/ARIC/)[25].
In brief, this is a large population-based sample of 15,792
individuals ascertained from a probability sample of four U.S.
communities between 1987 and 1989. Subjects were followed
every three years for several re-assessments (1990–1992, 1993–
1995, and 1996–1998) to study the incidence and course of
atherosclerosis in men and women aged 45–64 years at the time of
initial clinic assessment.
Genotyping
Samples were genotyped on the Affymetrix Genome-Wide
Human SNP Array 6.0 at the Broad Institute Center for
Genotyping and Analysis for the Gene Environment Association
Studies initiative (GENEVA, http://www.genevastudy.org). Ge-
notypes of 12,771 ARIC participants were submitted to dbGaP
and were available for analysis. For the present analyses, we first
excluded related individuals (n = 927; 11,844 remaining); subse-
quently, subjects with missing data on the Spielberger Trait Anger
Scale (n = 599; 11,245 remaining). Twenty percent of ARIC
participants were African American (AA) by self-report and the
remaining subjects classified only as ‘‘White’’ (i.e., individuals of
European ancestry (EA)). Using the online genetic power
calculator toolset [26], we determined the statistical power to
detect association at a quantitative trait locus (QTL) to account for
at least 1% of variance in the EA subsample to be 0.81; however,
the power to detect genome-wide statistically significant associa-
tions in the AA subgroup was substantially lower, at 0.21.
Therefore, we focused exclusively on the EA sample (with
n= 2,498 excluded and n= 8,747 remaining).
Quality Control
Extensive quality control checks were conducted on the original
data and we downloaded the cleaned dataset with genotypes
flagged for chromosomal abnormalities (n = 840,606 SNPs).
Within the selected sample of 8,747 subjects, we filtered SNPs
by minor allele frequency (MAF) conditional on call rate (CR)
including SNPs with: 0.01#MAF, 0.05 and CR.99%; 0.05#
MAF ,0.1 and CR .97%, MAF $0.1 and CR .95%
(n= 148,142 SNPs excluded). Any SNPs found to be out of
Hardy-Weinberg Equilibrium (p,1.0E-4) were excluded from
further consideration (n = 14,821 SNPs excluded). After applying
the described quality control filters, the final sample consisted of
677,643 SNPs in 8,747 unrelated subjects.
Spielberger State-Trait Anger Scale
The Spielberger State-Trait Anger Scale is a Likert-type four-
level self-rating scale (1 = almost never, 2 = sometimes, 3 = often,
4 = almost always) [27]. Factor analysis of the Trait Anger items
have yielded two weakly correlated (r2 = 0.29) factors labeled
‘‘Angry Temperament’’ and ‘‘Angry Reaction’’ [28]. The former
refers to the propensity of individuals to express anger frequently,
with little or no provocation, and includes four items: 1) I am quick
tempered, 2) I have a fiery temper, 3) I am a hotheaded person,
and 4) I fly off the handle. In contrast, the Angry Reaction
subscale reflects frustration in response to criticism or mistreat-
ment; it also includes four items: 1) I get angry when I am slowed
down by others’ mistakes, 2) I feel annoyed when I am not given
recognition for doing good work, 3) It makes me furious when I
am criticized in front of others, and 4) I feel infuriated when I do a
good job and get a poor evaluation. The items for each subscale
are summed to generate specific scores each ranging from 4 to 16.
Temperament scores above 8, and Reaction scores above 10, are
considered to be elevated and have been assessed as risk factors for
coronary heart disease outcomes in prior analyses of these data
[14].
The Spielberger State-Trait Anger scale was first adminstered at
visit 2 (1990–1992) in 8,747 subjects and again at visit 3 (1993–
1995) in 7,246 subjects; moderate to strong test-retest reliability for
the Angry Reaction (ICC=0.50) and the Angry Temperament
(ICC=0.65) subscales was observed. Subjects with missing
Spielberger State-Trait Anger scale data at visit 3 (n = 1,501)
had slightly higher visit 2 scores on the Angry Temperament
(6.061.9 vs. 5.761.7, p,0.0001) but not on the Angry Reaction
(7.662.2 vs. 7.662.1, p = 0.7) subscales. To maximize the sample
size, and to avoid misclassification of Angry Temperament at visit
3, we utilized information collected at visit 2 in this report.
Statistical Analysis
All genome-wide association analyses were conducted using
PLINK [29] employing datasets downloaded and filtered as
described earlier under genotyping. To control for multiplicity in
the number of SNPs tested, we adopted the conservative
recommendation of Dudbridge et al [30] and Pe’er et al [31],
considering p-values less than 7.0E-08 to be statistically significant
genome-wide. Our primary test of association was for the additive
effects of minor allele dosage on the quantitative summary scores
of Angry Temperament and Angry Reaction (each ranging from
4-16 points) in the selected sample. To further estimate magnitude
and direction of effect, we then conducted case-control analyses
(i.e., Angry Temperament .8 vs. #8 or Angry Reaction .10 vs.
#10) for SNPs of interest from the quantitative association results.
The potential for inflation of the test statistic due to population
heterogeneity was estimated with the lambda statistic (defined as
the observed median statistical test divided by the expected
GWAS of Proneness to Anger
PLOS ONE | www.plosone.org 2 January 2014 | Volume 9 | Issue 1 | e87257
median statistical test) and with quantile-quantile plots of observed
and expected p-values. To adjust for population stratification, we
conducted genome-wide association tests on the model residuals
generated for each anger phenotype regressed on the principal
components representing genetic substructure provided by the
ARIC investigators through dbGaP.
Gene Ontology (GO) Enrichment Analyses
Genetic enrichment or pathway analysis was conducted with the
INRICH pathway analysis tool for GWAS, designed for detection
of enriched association signals of linkage-disequilibrium (LD)
independent genomic regions within biologically relevant gene sets
(http://atgu.mgh.harvard.edu/inrich) [32]. Independent LD as-
sociation intervals were identified by the ‘‘clumping’’ algorithm in
PLINK [29]. This algorithm identifies genomic regions surround-
ing index SNPs (i.e. p,5E-05) defined by nearby SNPs (within
250 kb) that are in linkage disequilibrium (r2.0.4) with the index
SNP and are also nominally statistically significant (p,5E-03).
These association regions were referenced against genetic
categories defined by the Gene Ontology project (http://www.
geneontology.org/) according to known biological processes,
cellular components, and molecular function of their gene
products. For each GO term (e.g., ‘‘regulation of synaptic
plasticity’’) the number of association intervals containing genes
associated with that GO term were counted to determine if the
proportion of overlapping intervals is greater than expected by
chance through multiple permutation (n = 5,000 permutations).
The permutation procedure places each association interval at
random genomic locations but conditions on SNP/gene density to
control for potential bias associated with gene size and SNP
density.
Results
Data from 8,747 Caucasian men and women participating in
the ARIC study were included in our genome-wide association
analyses. Subjects were, on average 54.365.7 (range 45–64 years)
years old at baseline enrollment, 47% (n= 4,117) were men, and
all were of European descent by self-report. The mean Angry
Temperament and Angry Reaction scores were 5.861.8) and
7.662.2, respectively. Elevation of the Angry Reaction subscale
(.10, n= 845, 9.7%) was seen more often than elevation of the
Angry Temperament subscale (.8, n = 515, 5.9%).
Association with each anger phenotype was assessed across the
677,643 SNPs filtered by call rate conditional on minor allele
frequency and deviation from Hardy-Weinberg equilibrium. We
observed a potentially statistically significant finding (smallest
p = 2.9E-08) for Angry Temperament but not for Angry Reaction
(smallest p = 2.5E-07). The QQ plot (Figure 1) shows the
distribution of expected p-values against the observed distribution
for both Angry Temperament and Angry Reaction. Inspection of
the Angry Temperament plot clearly reveals a greater number of
significant findings than expected by chance with the distribution
of p-values being only slightly inflated (lambda=1.027). Adjust-
ment for genetic background reduced lambda to 1.0015 and
attenuated the uppermost findings (smallest pGC= 2.2E-07) but the
departure from the diagonal in the tail of both the corrected and
uncorrected QQ plots indicates enrichment of significant associ-
ations (Figure 1).
Table 1 lists the top 38 association regions defined by an index
SNP with nominal p,5E-05 and at least one additional proximal
SNP (,250 kb) in LD (r2.0.4) and significant at p,5E-03 for the
Angry Temperament subscale. We assessed enrichment of Gene
Ontology (GO) terms overlapping with association regions using
the INRICH algorithm to control for potential biases caused by
SNP/gene density and gene size. There was evidence of
enrichment for no GO targets among the top regional associations
for Angry Reaction scores (Table 2), but we found some nominal
evidence of enrichment for 6 GO targets (Table 3) in the Angry
Temperament association regions in Table 1 (none survived
correction for the number of targets tested). Among the targets
nominally significant at p,0.05, four genes overlap and are
Figure 1. Quantile-Quantile (QQ) plot of the genome-wide association results for the Spielberger State-Trait Anger Scale subscales.
The red symbols depict results from analysis uncorrected for ancestry, the blue symbols depict results corrected for ancestry (i.e. PGC), and the dashed
red line depicts the 95% confidence interval for the distribution of results. There was no evidence of inflation of the test statistic for the Angry
Reaction scores in the uncorrected (l =0.9998) or the corrected (l = 1.0029) analyses. For the Angry Temperament score test statistics, there was
slight inflation of the uncorrected analysis (l =1.0272) that was further reduced with correction for genetic ancestry (l = 1.0015).
doi:10.1371/journal.pone.0087257.g001
GWAS of Proneness to Anger
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present in more than one target: ABAT (4-aminobutyrate
aminotransferase), FYN (Fyn oncogene related to Src, Fgr, Yes),
PDE3A (phosphodiesterase 3A, cGMP-inhibited), and VEGFC
(vascular endothelial growth factor C).
Discussion
In this study we conducted a genome-wide association study of
trait anger in a large sample of middle-aged and elderly men and
women recruited from 4 large U.S. communities. We found
evidence of genetic susceptibility for the anger trait associated with
a proclivity for unprovoked (i.e., Angry Temperament scores) but
Table 1. Genome-Wide Association Results for the Angry Temperament subscale.
Temperament Score Case-Control LD-Based Association Interval
CHR SNP A1 BP MAF Beta P-RAW P-GC* OR P SNPs Length kb Genes
6 rs2148710 T 112,228,920 0.137 0.22 2.9E-08 4.6E-07 1.26 0.0075 12 135.32 FYN
7 rs6954895 G 35,552,732 0.257 0.16 2.1E-07 4.7E-06 1.24 0.0029 7 23.96 -
6 rs2844775 A 30,287,400 0.250 –0.15 8.3E-07 7.9E-05 0.87 0.0617 31 335.03 PPP1R11,RNF39,ZNRD1,
TRIM40,TRIM31,TRIM26,
TRIM15,TRIM10,HLA-
A29.1,HCG9
6 rs670292 C 150,744,544 0.466 0.13 1.6E-06 2.2E-07 1.24 0.0009 7 31.56 IYD
11 rs16924133 A 33,281,952 0.028 0.38 1.7E-06 2.1E-05 1.79 0.0001 4 245.99 TCP11L1,HIPK3,CSTF3
10 rs12249434 A 118,288,696 0.088 0.22 4.3E-06 1.2E-05 1.39 0.0013 3 50.64 PNLIP,PNLIPRP1
4 rs6834498 A 189,802,160 0.181 –0.16 4.9E-06 1.6E-05 0.86 0.0808 9 20.41 -
20 rs6012564 G 46,975,008 0.406 0.12 6.7E-06 1.1E-05 1.25 0.0007 12 242.31 STAU1,CSE1L,ARFGEF2
16 rs1299926 T 8,778,582 0.054 0.26 7.8E-06 2.3E-05 1.54 0.0003 2 5.12 ABAT
19 rs8102754 A 34,180,880 0.454 0.12 8.3E-06 8.9E-05 1.24 0.0010 2 7.32 -
1 rs16840114 C 238,692,048 0.060 0.25 9.1E-06 6.7E-05 1.39 0.0055 2 0.55 FMN2
1 rs4628571 C 208,925,024 0.449 –0.12 1.0E-05 9.3E-05 0.83 0.0048 11 57.03 KCNH1,HHAT
20 rs238215 T 47,303,912 0.235 –0.14 1.2E-05 6.4E-06 0.79 0.0036 9 120.68 ZNFX1,STAU1,DDX27
4 rs11724215 G 89,020,656 0.070 0.23 1.3E-05 2.1E-04 1.42 0.0019 4 40.93 MEPE
6 rs782000 G 71,408,536 0.272 0.13 1.4E-05 6.0E-05 1.27 0.0006 3 149.06 SMAP1
4 rs17084746 C 52,666,560 0.011 0.55 1.8E-05 8.2E-05 1.82 0.0125 4 83.61 SPATA18
6 rs7742473 A 119,208,432 0.098 0.19 1.9E-05 2.3E-05 1.21 0.0610 5 13.40 -
20 rs1883881 T 46,999,184 0.349 –0.12 2.0E-05 1.6E-05 0.78 0.0004 12 245.59 STAU1,CSE1L, ARFGEF2
12 rs10770687 G 20,701,778 0.348 –0.12 2.3E-05 2.9E-04 0.92 0.2281 7 48.40 SLCO1C1,PDE3A
11 rs4758435 C 5,798,432 0.190 0.14 2.5E-05 9.8E-05 1.25 0.0041 2 1.28 OR52N2
1 rs2495053 C 13,912,617 0.053 0.25 2.6E-05 1.1E-04 1.35 0.0181 3 134.60 PRDM2
1 rs6668091 T 239,578,176 0.143 0.16 2.6E-05 1.7E-04 1.22 0.0221 5 33.04 RGS7
4 rs41501449 C 178,024,608 0.105 –0.18 2.7E-05 1.8E-04 0.71 0.0033 14 173.27 VEGFC
14 rs17831706 T 51,825,136 0.090 0.20 2.7E-05 3.7E-05 1.43 0.0003 3 34.52 PTGDR
1 rs10912593 A 169,454,688 0.315 0.12 3.0E-05 4.8E-05 1.20 0.0062 3 39.34 FMO2
1 rs3889128 G 53,781,820 0.235 0.13 3.1E-05 3.7E-05 1.17 0.0319 3 0.14 GLIS1
2 rs2341997 G 16,835,468 0.440 0.11 3.3E-05 1.5E-04 1.07 0.3060 2 7.48 -
9 rs7035071 C 2,069,250 0.200 –0.14 3.5E-05 2.1E-04 0.85 0.0461 2 7.86 SMARCA2
7 rs10258797 A 121,796,040 0.207 0.14 3.6E-05 3.1E-04 1.29 0.0008 4 46.00 CADPS2
12 rs215996 C 2,589,558 0.182 0.14 3.6E-05 1.9E-04 1.20 0.0203 5 17.18 CACNA1C
6 rs583807 T 4,100,791 0.081 –0.20 3.7E-05 2.0E-05 0.71 0.0094 5 65.89 -
1 rs17373189 C 172,636,384 0.157 –0.15 3.9E-05 1.7E-04 0.75 0.0026 17 358.45 RABGAP1L,GPR52
18 rs17596183 A 34,730,256 0.363 –0.11 4.1E-05 1.7E-04 0.86 0.0294 10 31.34 -
23 rs2354304 A 94,283,280 0.432 0.09 4.2E-05 7.1E-05 1.29 0.0008 12 23.20 -
23 rs2272657 A 48,203,844 0.374 0.09 4.5E-05 4.0E-04 1.22 0.0103 3 10.48 SLC38A5
23 rs543042 A 146,406,080 0.142 –0.13 4.5E-05 1.5E-05 0.72 0.0061 17 143.24 -
8 rs7843469 A 69,360,592 0.440 0.11 4.6E-05 1.5E-04 1.14 0.0420 6 23.21 -
11 rs2712799 G 74,526,864 0.379 0.11 4.8E-05 1.0E-04 1.10 0.1340 14 74.05 SLCO2B1,OR2AT4
*p-values results from phenotypes adjusted for principal components representing genetic substructure of ARIC participants.
doi:10.1371/journal.pone.0087257.t001
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not provoked (i.e., Angry Reaction scores) anger. In contrast to the
Angry Reaction results, for Angry Temperament we identified a
greater than expected number of extreme p-values and nominal
evidence of GO target enrichment.
We have previously studied mood dysregulation using data from
the ADHD sub study of the Psychiatric Genomics Consortium
(PGC) [23]. In this study of 341 referred ADHD assessed with the
Child-Behavior Checklist [23,33], we found suggestive but weak
associations with BDNF (brain-derived neurotrophic factor), it’s
preferred receptor (NTKR2, neurotrophic tyrosine kinase receptor,
type 2), and a scaffolding protein (LRRC7, leucine rich repeat
containing 7) anchoring a downstream protein kinase (CAMK2A,
calcium/calmodulin-dependent protein kinase II alpha) required
for initiation and maintenance of early-long-term potentiation
[34,35]. We also found preliminary evidence of association with
prion protein (PRNP) and it’s ligand (STIP1; stress-induced-
phosphoprotein) that together mediate astrocyte differentiation/
survival [36,37] and homeostatic function of hippocampal circuits
[38]. Disruption of STIP1-PRPN or BDNF-NTKR2 binding in
the hippocampus [39–41] impair long-term potentiation, spatial
learning, memory consolidation, and hippocampal development.
The most statistically significant association in the current study
was with rs2148710 and the Angry Temperament score in FYN.
Interestingly, the mechanisms underlying the pathways suggested
by our small studies of mood dysregulation in children are
dependent on Fyn activity. For example, post-synaptic BDNF-
NTRK2 binding activates Fyn to phosphorylate NDMA-receptors
(N-methyl-d-aspartate) and increases subsequent calcium influx
associated with long-term potentiation initiation [35,42,43]. Fyn
also phosphorylates endoplasmic reticulum inositol-1,4,5-trispho-
sphate (IP3)-gated channels to stimulate the release of intracellular
calcium [44,45] in response to both NTKR2 [35] and PRNP [46]
activity.
Loss of Fyn function in mice has also been associated with
blunted long-term potentiation at hippocampal synapses and
impaired learning and memory on the hidden platform water
maze task [47]. These findings are consistent with learning-
disordered/transactional model of explosive anger in which
lagging higher-order cognitive skills play a central role [48,49].
Specific executive functioning deficits could contribute to explosive
reactivity through inefficient encoding of previous consequences of
noncompliance, thereby interfering with the ability to anticipate
consequences of potential actions [49].
The Psychiatric Genomics Consortium (PGC) [50] has recently
published cross- disorder analyses documenting pleiotropic effects
of associated genes for psychiatric disorders that suggest a common
genetic susceptibilities that underlie psychiatric morbidity. These
pleiotropic genetic variants in the PGC analyses were enriched for
brain expression quantitative trait loci (eQTL) and more
specifically for calcium channel activity genes facilitating trans-
membrane ion diffusion (GO:0005262, calcium channel activity).
Interestingly, we also observed a nominal association with a SNP
in CACNA1C and Angry Temperament in our association analyses
(Table 1). CACNA1C encodes the a subunit of the L-type voltage-
gated calcium channel and is a strong candidate for both bipolar
disorder and general psychiatric morbidity [32,50]. Thus, our
results may suggest that regulation of calcium-dependent intracel-
lular signaling could play a role not only for psychiatric morbidity
but also for variable expression of normative symptoms such as
anger.
GO enrichment analyses suggest that there may be shared
genetic susceptibility for affect regulation and cardiovascular
disease, as well. Using these data, other groups have documented
an increased risk for coronary heart disease with an elevated
proneness to anger [13,14,17,51,52], and we have found
nominally significant (p,0.05) enrichment of genes associated
Table 2. Genome-Wide Association Results for the Angry Reaction subscale.
Reaction Score Case-Control LD-Based Association Interval
CHR SNP A1 BP MAF P-HWE Beta P-RAW P-GC* OR P SNPs Length (kb) Interval Genes
23 rs3752433 A 22,149,640 0.312 0.392 0.15 2.5E-07 1.6E-07 1.181 0.0067 14 41.451 PHEX
6 rs555017 T 20,293,030 0.369 0.065 0.15 4.0E-06 8.8E-06 1.221 0.00012 3 8.696 MBOAT1
2 rs7578047 C 68,433,432 0.142 0.670 –0.22 4.4E-06 5.8E-06 0.7164 0.000043 7 62.651 PLEK
4 rs2045797 C 103,572,096 0.422 0.915 –0.15 1.1E-05 1.0E-05 0.8443 0.0012 16 109.868 SLC39A8
3 rs17535407 C 105,381,760 0.406 0.003 0.15 1.8E-05 1.0E-05 1.176 0.0018 2 8.094 -
16 rs3922878 C 85,412,208 0.034 0.006 –0.38 2.5E-05 3.5E-05 0.5534 0.00091 3 12.691 -
8 rs3110145 T 60,204,964 0.138 0.013 –0.20 2.5E-05 2.4E-05 0.7081 0.00003 9 129.854 TOX
16 rs10863202 A 84,545,496 0.301 0.139 0.15 2.7E-05 6.0E-05 1.165 0.0053 7 6.522 -
10 rs11201163 A 86,420,712 0.330 0.815 –0.14 2.7E-05 2.8E-05 0.8214 0.00044 5 36.769 -
3 rs12639503 T 51,835,856 0.023 0.148 0.45 3.2E-05 2.6E-05 1.522 0.0045 4 71.18 IQCF2,IQCF3
7 rs10271531 T 80,951,880 0.057 0.501 0.29 3.6E-05 3.5E-05 1.485 0.000037 9 160.549 -
8 rs2572430 T 11,142,714 0.450 0.071 –0.14 3.7E-05 3.9E-03 0.8764 0.011 13 78.835 MTMR9
3 rs1387024 C 114,030,288 0.351 0.699 –0.14 3.7E-05 4.1E-05 0.8734 0.013 6 141.936 CD200R1,CD200R2
8 rs7012323 G 127,651,008 0.247 0.867 –0.16 3.9E-05 3.6E-05 0.8366 0.0037 2 3.323 -
8 rs7820917 T 9,685,278 0.378 0.402 –0.14 3.9E-05 2.9E-03 0.9107 0.078 18 378.211 TNKS
3 rs1878012 C 21,822,622 0.213 0.536 0.16 4.4E-05 3.8E-05 1.251 0.00016 3 4.205 -
9 rs1160245 A 119,032,744 0.490 0.025 0.13 4.4E-05 5.9E-05 1.197 0.00046 17 38.647 ASTN2
5 rs6874556 C 132,619,432 0.426 0.330 0.13 5.0E-05 4.7E-05 1.101 0.061 4 17.986 FSTL4
*p-values results from phenotypes adjusted for principal components representing genetic substructure of ARIC participants.
doi:10.1371/journal.pone.0087257.t002
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with the negative regulation of blood pressure (GO:0045776;
ABAT and VEGFC) and platelet activation (GO:0030168; FYN,
VEGFC, and PDE3A) in our study of Angry Temperament (Table
3). In addition to impacting hippocampal memory and learning,
Fyn is involved with the regulation of platelet shape/response [53]
and cardiac myocyte excitability by modulating voltage-gated
cardiac sodium channels [54]. Similarly, ABAT, a metabolizer of
the inhibitory neurotransmitter GABA, is associated with negative
regulation of blood pressure and has previously been associated
with disorders (e.g., schizophrenia [55] and autism [56]) that are
associated with angry, aggressive behavior. Though the overlap-
ping patterns of association might represent pleiotropic genes, they
also might be the result of a confounding by phenotypic
correlation (e.g., between affect regulation and cardiovascular
disease) [57].
We have evaluated these results in the context of methodolog-
ical limitations, including considerations that (a) replication studies
for this phenotype are not yet available, (b) the measures
demonstrated moderate test-retest reliability, and (c) our available
sample size may be inadequate to identify genome-wide statisti-
cally significant associations that survive correction for population
stratification. This may weaken the strength of association for the
regions identified and, consequently, no targets survived correction
for the number of GO categories evaluated for enrichment. (4)
Another limitation exists with respect to the range of ethnicity:
there was only a modest number of African American subjects,
thus we limited our analyses and generalizability to individuals of
European descent.
These limitations notwithstanding, the differences in the
distribution of results for the Angry Temperament and Angry
Reaction phenotypes are noteworthy. The null results observed for
Angry Reaction scores (i.e., an absence of any inflation of test
statistic, extreme p-values, or evidence of GO enrichment among
top findings) suggest that the associations observed for Angry
Temperament may not be due to chance alone, particularly since
both scores were generated from a single questionnaire. Compared
to those of the Angry Reaction phenotype, the behavioral
characteristics measured by the Angry Temperament items
(unprovoked, frequent, and extreme anger) more closely resemble
the behavioral characteristics of the childhood phenotype --- ones
that resulted in putative associations with genes involved in
hippocampal synaptic plasticity, memory and learning [23]. The
substantial clinical impact of this form of dysregulated emotion on
interpersonal functioning [5,11] and cardiovascular health [14,15]
strongly suggests that additional etiologic research is indicated in
order to identify targets for primary and secondary interventions
across the life-cycle.
Acknowledgments
Phenotypes and genotypes were downloaded from the National
Center for Biotechnology Information (NCBI) database of
genotypes and phenotypes (dbGaP) for the NHLBI funded
Atherosclerosis Risk in Communities (ARIC) Study (Accessions:
phs000280.v1.p1 and phs000090.v1.p1). The authors thank the
staff and participants of the ARIC study for their important
contributions.
Author Contributions
Conceived and designed the experiments: EM JM CD RG. Analyzed the
data: EM. Wrote the paper: EM JM CD JF DK RG.
References
1. Leibenluft E (2011) Severe mood dysregulation, irritability, and the diagnostic
boundaries of bipolar disorder in youths. The American journal of psychiatry
168: 129–142.
2. Barkley RA, Fischer M (2010) The unique contribution of emotional
impulsiveness to impairment in major life activities in hyperactive children as
adults. Journal of the American Academy of Child and Adolescent Psychiatry
49: 503–513.
3. Hudziak J, Althoff RR, Rettew DC, Derks EM, Faraone SV (2005) The
prevalence and genetic architecture of CBCL-juvenile bipolar disorder.
Biological Psychiatry 58: 562–568.
4. Volk HE, Todd RD (2007) Does the Child Behavior Checklist juvenile bipolar
disorder phenotype identify bipolar disorder? Biol Psychiatry 62: 115–120.
5. Kessler RC, Coccaro EF, Fava M, Jaeger S, Jin R, et al. (2006) The prevalence
and correlates of DSM-IV intermittent explosive disorder in the National
Comorbidity Survey Replication. Archives of general psychiatry 63: 669–678.
6. Youngstrom E, Youngstrom JK, Starr M (2005) Bipolar diagnoses in community
mental health: Achenbach Child Behavior Checklist profiles and patterns of
comorbidity. Biol Psychiatry 58: 569–575.
7. Diler RS, Birmaher B, Axelson D, Goldstein B, Gill M, et al. (2009) The Child
Behavior Checklist (CBCL) and the CBCL-bipolar phenotype are not useful in
diagnosing pediatric bipolar disorder. J Child Adolesc Psychopharmacol 19: 23–
30.
8. Meyer SE, Carlson GA, Youngstrom E, Ronsaville DS, Martinez PE, et al.
(2009) Long-term outcomes of youth who manifested the CBCL-Pediatric
Bipolar Disorder phenotype during childhood and/or adolescence. J Affect
Disord 113: 227–235.
9. Biederman J, Petty CR, Monuteaux MC, Evans M, Parcell T, et al. (2009) The
child behavior checklist-pediatric bipolar disorder profile predicts a subsequent
diagnosis of bipolar disorder and associated impairments in ADHD youth
growing up: a longitudinal analysis. J Clin Psychiatry 70: 732–740.
10. Ayer L, Althoff R, Ivanova M, Rettew D, Waxler E, et al. (2009) Child Behavior
Checklist Juvenile Bipolar Disorder (CBCL-JBD) and CBCL Posttraumatic
Stress Problems (CBCL-PTSP) scales are measures of a single dysregulatory
syndrome. J Child Psychol Psychiatry 50: 1291–1300.
11. Althoff RR, Verhulst FC, Rettew DC, Hudziak JJ, van der Ende J (2010) Adult
outcomes of childhood dysregulation: a 14-year follow-up study. J Am Acad
Child Adolesc Psychiatry 49: 1105–1116.
12. Iribarren C, Jacobs DR, Kiefe CI, Lewis CE, Matthews KA, et al. (2005) Causes
and demographic, medical, lifestyle and psychosocial predictors of premature
mortality: the CARDIA study. Social science & medicine 60: 471–482.
Table 3. Gene Ontology (GO) Enrichment Results.
GO Target Category
Empirical p-
value
Corrected p-
value Associated Genes
GO:0045776 Negative regulation of blood pressure .00039 0.30 ABAT, VEGFC
GO:0043252 Sodium-independent organic anion transport .00059 0.35 SLCO2B1, SLCO1C1
GO:0004386 Helicase activity .0088 0.88 SMARCA2, DDX27
GO:0045471 Response to ethanol .017 0.95 ABAT, FYN
GO:0042493 Response to drug .029 0.98 ABAT, VEGFC, PDE3A
GO:0030168 Platelet activation .030 0.98 FYN, VEGFC, PDE3A
doi:10.1371/journal.pone.0087257.t003
GWAS of Proneness to Anger
PLOS ONE | www.plosone.org 6 January 2014 | Volume 9 | Issue 1 | e87257
13. Williams JE, Paton CC, Siegler IC, Eigenbrodt ML, Nieto FJ, et al. (2000) Anger
proneness predicts coronary heart disease risk: prospective analysis from the
atherosclerosis risk in communities (ARIC) study. Circulation 101: 2034–2039.
14. Williams JE, Nieto FJ, Sanford CP, Tyroler HA (2001) Effects of an angry
temperament on coronary heart disease risk : The Atherosclerosis Risk in
Communities Study. American journal of epidemiology 154: 230–235.
15. Kubzansky LD, Park N, Peterson C, Vokonas P, Sparrow D (2011) Healthy
Psychological Functioning and Incident Coronary Heart Disease: The
Importance of Self-regulation. Archives of general psychiatry 68: 400–408.
16. Iribarren C, Sidney S, Bild DE, Liu K, Markovitz JH, et al. (2000) Association of
hostility with coronary artery calcification in young adults: the CARDIA study.
Coronary Artery Risk Development in Young Adults. JAMA : the journal of the
American Medical Association 283: 2546–2551.
17. Williams JE, Couper DJ, Din-Dzietham R, Nieto FJ, Folsom AR (2007) Race-
gender differences in the association of trait anger with subclinical carotid artery
atherosclerosis: the Atherosclerosis Risk in Communities Study. American
journal of epidemiology 165: 1296–1304.
18. Player MS, King DE, Mainous AG, 3rd, Geesey ME (2007) Psychosocial factors
and progression from prehypertension to hypertension or coronary heart disease.
Annals of family medicine 5: 403–411.
19. Surman CB, Biederman J, Spencer T, Yorks D, Miller CA, et al. (2011)
Deficient emotional self-regulation and adult attention deficit hyperactivity
disorder: a family risk analysis. The American journal of psychiatry 168: 617–
623.
20. Coccaro EF, Ong AD, Seroczynski D, Bergeman CS (2011) Affective intensity
and lability: Heritability in adult male twins. Journal of affective disorders.
21. Althoff RR, Rettew DC, Faraone SV, Boomsma DI, Hudziak JJ (2006) Latent
class analysis shows strong heritability of the child behavior checklist-juvenile
bipolar phenotype. Biol Psychiatry 60: 903–911.
22. Hudziak JJ, Derks EM, Althoff RR, Rettew DC, Boomsma DI (2005) The
genetic and environmental contributions to attention deficit hyperactivity
disorder as measured by the conners’ rating scales--revised. Am J Psychiatry
162: 1614–1620.
23. Mick E, McGough J, Loo S, Doyle AE, Wozniak J, et al. (2011) Genome-wide
association study of the child behavior checklist dysregulation profile. Journal of
the American Academy of Child and Adolescent Psychiatry 50: 807–817 e808.
24. Mailman MD, Feolo M, Jin Y, Kimura M, Tryka K, et al. (2007) The NCBI
dbGaP database of genotypes and phenotypes. Nature Genetics 39: 1181–1186.
25. The ARIC Investigators (1989) The atherosclerosis risk in communities (ARIC)
study: design and objectives. American journal of epidemiology 129: 687–702.
26. Purcell S, Cherny SS, Sham PC (2003) Genetic Power Calculator: design of
linkage and association genetic mapping studies of complex traits. Bioinformatics
19: 149–150.
27. Spielberger CD, Jacobs G, Russell S, Crane RS (1983) Assessment of anger: The
state-trait anger scale. In: Butcher JN, Spielberger CD, editors. Advances in
Personality Assessment. Hillsdale, NJ: Lawrence Erlbaum Associates. pp. 161–
189.
28. Gold AE, Johhnston DW (1996) Anger, hypertension and heart disease. In:
Bennett P, Weinman J, Spurgeon P, editors. Current Developments in Health
Psychology. 2nd ed. Amsterdam: Harwood Acedemic Publishers. pp. 105–128.
29. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007)
PLINK: a tool set for whole-genome association and population-based linkage
analyses. Am J Hum Genet 81: 559–575.
30. Dudbridge F, Gusnanto A (2008) Estimation of significance thresholds for
genomewide association scans. Genet Epidemiol 32: 227–234.
31. Pe’er I, Yelensky R, Altshuler D, Daly MJ (2008) Estimation of the multiple
testing burden for genomewide association studies of nearly all common variants.
Genet Epidemiol 32: 381–385.
32. Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S, et al. (2011) Large-scale
genome-wide association analysis of bipolar disorder identifies a new
susceptibility locus near ODZ4. Nature genetics 43: 977–983.
33. Mick E, Monuteaux M, Wilens TE, Wozniak J, Byrne D, et al. A Genetic
association study of emotional dysregulation indexed by the Child Behavior
Checklist (CBCL) in Children with Attention-Deficit/Hyperactivity Disorder
(ADHD); 2010 10/2010; New York. AACAP.
34. Thalhammer A, Trinidad JC, Burlingame AL, Schoepfer R (2009) Densin-180:
revised membrane topology, domain structure and phosphorylation status. J
Neurochem 109: 297–302.
35. Minichiello L (2009) TrkB signalling pathways in LTP and learning. Nature
reviews Neuroscience 10: 850–860.
36. Lopes MH, Hajj GN, Muras AG, Mancini GL, Castro RM, et al. (2005)
Interaction of cellular prion and stress-inducible protein 1 promotes neuritogen-
esis and neuroprotection by distinct signaling pathways. J Neurosci 25: 11330–
11339.
37. Arantes C, Nomizo R, Lopes MH, Hajj GN, Lima FR, et al. (2009) Prion
protein and its ligand stress inducible protein 1 regulate astrocyte development.
Glia 57: 1439–1449.
38. Rangel A, Madronal N, Gruart A, Gavin R, Llorens F, et al. (2009) Regulation
of GABA(A) and glutamate receptor expression, synaptic facilitation and long-
term potentiation in the hippocampus of prion mutant mice. PloS one 4: e7592.
39. Coitinho AS, Lopes MH, Hajj GN, Rossato JI, Freitas AR, et al. (2007) Short-
term memory formation and long-term memory consolidation are enhanced by
cellular prion association to stress-inducible protein 1. Neurobiol Dis 26: 282–
290.
40. Minichiello L, Korte M, Wolfer D, Kuhn R, Unsicker K, et al. (1999) Essential
role for TrkB receptors in hippocampus-mediated learning. Neuron 24: 401–
414.
41. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, et al. (1995) Hippocampal
long-term potentiation is impaired in mice lacking brain-derived neurotrophic
factor. Proceedings of the National Academy of Sciences of the United States of
America 92: 8856–8860.
42. Levine ES, Crozier RA, Black IB, Plummer MR (1998) Brain-derived
neurotrophic factor modulates hippocampal synaptic transmission by increasing
N-methyl-D-aspartic acid receptor activity. Proceedings of the National
Academy of Sciences of the United States of America 95: 10235–10239.
43. Mizuno M, Yamada K, He J, Nakajima A, Nabeshima T (2003) Involvement of
BDNF receptor TrkB in spatial memory formation. Learning & memory 10:
108–115.
44. Jayaraman T, Ondrias K, Ondriasova E, Marks AR (1996) Regulation of the
inositol 1,4,5-trisphosphate receptor by tyrosine phosphorylation. Science 272:
1492–1494.
45. Vanderheyden V, Devogelaere B, Missiaen L, De Smedt H, Bultynck G, et al.
(2009) Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by
reversible phosphorylation and dephosphorylation. Biochimica et biophysica
acta 1793: 959–970.
46. Krebs B, Wiebelitz A, Balitzki-Korte B, Vassallo N, Paluch S, et al. (2007)
Cellular prion protein modulates the intracellular calcium response to hydrogen
peroxide. Journal of neurochemistry 100: 358–367.
47. Grant SG, O’Dell TJ, Karl KA, Stein PL, Soriano P, et al. (1992) Impaired long-
term potentiation, spatial learning, and hippocampal development in fyn mutant
mice. Science 258: 1903–1910.
48. Greene RW, Doyle AE (1999) Toward a transactional conceptualization of
oppositional defiand disorder: Implications for assessment and treatment.
Clinical Child and Family Psychology Review 2: 129–148.
49. Greene RW, Ablon JS, Goring JC (2003) A transactional model of oppositional
behavior: underpinnings of the Collaborative Problem Solving approach. J
Psychosom Res 55: 67–75.
50. Cross-Disorder Group of the Psychiatric Genomics C, Lee SH, Ripke S, Neale
BM, Faraone SV, et al. (2013) Genetic relationship between five psychiatric
disorders estimated from genome-wide SNPs. Nat Genet 45: 984–994.
51. Williams JE, Nieto FJ, Sanford CP, Couper DJ, Tyroler HA (2002) The
association between trait anger and incident stroke risk: the Atherosclerosis Risk
in Communities (ARIC) Study. Stroke; a journal of cerebral circulation 33: 13–
19.
52. Williams JE, Din-Dzietham R, Szklo M (2006) Trait anger and arterial stiffness:
results from the Atherosclerosis Risk in Communities (ARIC) study. Preventive
cardiology 9: 14–20.
53. Kim S, Kunapuli SP (2011) Negative regulation of Gq-mediated pathways in
platelets by G(12/13) pathways through Fyn kinase. The Journal of biological
chemistry 286: 24170–24179.
54. Ahern CA, Zhang JF, Wookalis MJ, Horn R (2005) Modulation of the cardiac
sodium channel NaV1.5 by Fyn, a Src family tyrosine kinase. Circulation
research 96: 991–998.
55. Jia P, Wang L, Meltzer HY, Zhao Z (2010) Common variants conferring risk of
schizophrenia: a pathway analysis of GWAS data. Schizophrenia research 122:
38–42.
56. Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, et al.
(2009) Genes related to sex steroids, neural growth, and social-emotional
behavior are associated with autistic traits, empathy, and Asperger syndrome.
Autism research : official journal of the International Society for Autism
Research 2: 157–177.
57. Vansteelandt S, Goetgeluk S, Lutz S, Waldman I, Lyon H, et al. (2009) On the
adjustment for covariates in genetic association analysis: a novel, simple principle
to infer direct causal effects. Genetic Epidemiology 33: 394–405.
GWAS of Proneness to Anger
PLOS ONE | www.plosone.org 7 January 2014 | Volume 9 | Issue 1 | e87257
